Bids Open for CN National Centralized Medicines Procurement, Covering 316 Common Medications
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2h ago
0mins
Should l Buy ?
Source: aastocks
Procurement Announcement: China's National Healthcare Security Administration (NHSA) revealed preliminary results for a new round of centralized medicine procurement, involving 316 types of common drugs and 4,163 products from 1,020 companies.
Therapeutic Areas Covered: The follow-up procurement spans 26 therapeutic areas, including anti-infection, anti-tumor, and various systems such as nervous, respiratory, and digestive.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
